- Home
- SLVM vs LGND Comparison
SLVM vs LGND Comparison
Compare SLVM & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLVM
- LGND
- Stock Information
- Founded
- SLVM 1898
- LGND 1987
- Country
- SLVM United States
- LGND United States
- Employees
- SLVM N/A
- LGND N/A
- Industry
- SLVM Paper
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- SLVM Basic Materials
- LGND Health Care
- Exchange
- SLVM Nasdaq
- LGND Nasdaq
- Market Cap
- SLVM 2.5B
- LGND 2.1B
- IPO Year
- SLVM N/A
- LGND 1992
- Fundamental
- Price
- SLVM $52.57
- LGND $104.48
- Analyst Decision
- SLVM Hold
- LGND Strong Buy
- Analyst Count
- SLVM 3
- LGND 8
- Target Price
- SLVM $92.00
- LGND $144.71
- AVG Volume (30 Days)
- SLVM 321.5K
- LGND 104.5K
- Earning Date
- SLVM 05-09-2025
- LGND 05-08-2025
- Dividend Yield
- SLVM 3.42%
- LGND N/A
- EPS Growth
- SLVM 45.68
- LGND N/A
- EPS
- SLVM 6.84
- LGND N/A
- Revenue
- SLVM $3,689,000,000.00
- LGND $181,488,000.00
- Revenue This Year
- SLVM N/A
- LGND $16.47
- Revenue Next Year
- SLVM $0.65
- LGND $19.44
- P/E Ratio
- SLVM $7.70
- LGND N/A
- Revenue Growth
- SLVM 0.11
- LGND 53.40
- 52 Week Low
- SLVM $54.94
- LGND $72.61
- 52 Week High
- SLVM $98.02
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- SLVM 29.98
- LGND 46.11
- Support Level
- SLVM $58.46
- LGND $99.24
- Resistance Level
- SLVM $60.51
- LGND $107.37
- Average True Range (ATR)
- SLVM 1.83
- LGND 4.05
- MACD
- SLVM -0.14
- LGND -0.33
- Stochastic Oscillator
- SLVM 8.40
- LGND 39.37
About SLVM Sylvamo Corporation
Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills, it produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.